|
Name |
paecilin I
|
| Molecular Formula | C35H38O13 | |
| IUPAC Name* |
methyl8-(1,8-dihydroxy-10a-methoxycarbonyl-5,6-dimethyl-9-oxo-6,7-dihydro-5H-xanthen-2-yl)-5-hydroxy-2-(5-methoxy-3-methyl-5-oxopentan-2-yl)-4-oxo-3H-chromene-2-carboxylate
|
|
| SMILES |
COC(=O)CC(C)C(C)C1(C(=O)OC)CC(=O)c2c(O)ccc(-c3ccc4c(c3O)C(=O)C3=C(O)CC(C)C(C)C3(C(=O)OC)O4)c2O1
|
|
| InChI |
InChI=1S/C35H38O13/c1-15-12-22(37)28-30(41)27-24(47-35(28,18(15)4)33(43)46-7)11-9-19(29(27)40)20-8-10-21(36)26-23(38)14-34(32(42)45-6,48-31(20)26)17(3)16(2)13-25(39)44-5/h8-11,15-18,36-37,40H,12-14H2,1-7H3/t15-,16-,17+,18+,34-,35-/m0/s1
|
|
| InChIKey |
KYBZYRFLEIIBES-XYWBEIDYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 666.68 | ALogp: | 4.5 |
| HBD: | 3 | HBA: | 13 |
| Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 192.2 | Aromatic Rings: | 5 |
| Heavy Atoms: | 48 | QED Weighted: | 0.266 |
| Caco-2 Permeability: | -5.115 | MDCK Permeability: | 0.00002090 |
| Pgp-inhibitor: | 0.979 | Pgp-substrate: | 0.006 |
| Human Intestinal Absorption (HIA): | 0.35 | 20% Bioavailability (F20%): | 0.002 |
| 30% Bioavailability (F30%): | 0.719 |
| Blood-Brain-Barrier Penetration (BBB): | 0.012 | Plasma Protein Binding (PPB): | 93.39% |
| Volume Distribution (VD): | 0.554 | Fu: | 2.99% |
| CYP1A2-inhibitor: | 0.034 | CYP1A2-substrate: | 0.9 |
| CYP2C19-inhibitor: | 0.412 | CYP2C19-substrate: | 0.625 |
| CYP2C9-inhibitor: | 0.784 | CYP2C9-substrate: | 0.333 |
| CYP2D6-inhibitor: | 0.052 | CYP2D6-substrate: | 0.192 |
| CYP3A4-inhibitor: | 0.939 | CYP3A4-substrate: | 0.79 |
| Clearance (CL): | 10.904 | Half-life (T1/2): | 0.022 |
| hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.896 |
| Drug-inuced Liver Injury (DILI): | 0.962 | AMES Toxicity: | 0.018 |
| Rat Oral Acute Toxicity: | 0.977 | Maximum Recommended Daily Dose: | 0.301 |
| Skin Sensitization: | 0.014 | Carcinogencity: | 0.041 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
| Respiratory Toxicity: | 0.024 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005729 | ![]() |
0.727 | D0T5XN | ![]() |
0.280 | ||
| ENC003346 | ![]() |
0.709 | D07IPB | ![]() |
0.265 | ||
| ENC005727 | ![]() |
0.660 | D01UBX | ![]() |
0.263 | ||
| ENC003347 | ![]() |
0.654 | D0Q0PR | ![]() |
0.259 | ||
| ENC005728 | ![]() |
0.613 | D01XWG | ![]() |
0.254 | ||
| ENC005732 | ![]() |
0.609 | D07VLY | ![]() |
0.250 | ||
| ENC005735 | ![]() |
0.589 | D0C9XJ | ![]() |
0.250 | ||
| ENC006115 | ![]() |
0.583 | D01XDL | ![]() |
0.247 | ||
| ENC005885 | ![]() |
0.558 | D0FX2Q | ![]() |
0.242 | ||
| ENC005736 | ![]() |
0.541 | D0T8EH | ![]() |
0.239 | ||